Abraxane/Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus
- Status
- COMPLETED
- Phase
- N/A
PET-CT vs. Integrated MR-PET Scanning of GYN Cancers
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Oxford Ovarian Cancer Predict Chemotherapy Response 01
- Status
- UNKNOWN
- Phase
- N/A
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
18F-CP18 Imaging Studies for Cancer Treatment With Birinapant
- Status
- WITHDRAWN
- Phase
- PHASE2
Cabazitaxel in Platinum Refractory Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- NA
The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility Study
- Status
- TERMINATED
- Phase
- NA
A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially Unresectable
- Status
- COMPLETED
- Phase
- PHASE2
Elecsys HE4 Chinese Reference Value Study
- Status
- COMPLETED
- Phase
- N/A
Sentinel Node Detection in Clinical Early Stage Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Strength Training Study for Survivors of Breast and Gynecologic Cancer
- Status
- COMPLETED
- Phase
- NA
Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab
- Status
- UNKNOWN
- Phase
- PHASE4
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Accelerating Gastrointestinal Recovery
- Status
- COMPLETED
- Phase
- PHASE3
SGI-110 in Combination With Carboplatin in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2